NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Akoya Biosciences Inc (NASDAQ: AKYA)
AKYA Technical Analysis
5
As on 9th Jun 2023 AKYA STOCK Price closed @ 5.37 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 11.99 & Strong Sell for SHORT-TERM with Stoploss of 12.06 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AKYASTOCK Price
Open | 5.36 | Change | Price | % |
High | 5.60 | 1 Day | 0.09 | 1.70 |
Low | 5.15 | 1 Week | -0.07 | -1.29 |
Close | 5.37 | 1 Month | -1.36 | -20.21 |
Volume | 642909 | 1 Year | -7.01 | -56.62 |
52 Week High 15.76 | 52 Week Low 5.44 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
AKYA Daily Charts |
AKYA Intraday Charts |
Whats New @ Bazaartrend |
AKYA Free Analysis |
|
AKYA Important Levels Intraday
RESISTANCE | 6.24 |
RESISTANCE | 5.96 |
RESISTANCE | 5.79 |
RESISTANCE | 5.62 |
SUPPORT | 5.12 |
SUPPORT | 4.95 |
SUPPORT | 4.78 |
SUPPORT | 4.50 |
AKYA Forecast April 2024
4th UP Forecast | 14.18 |
3rd UP Forecast | 11.35 |
2nd UP Forecast | 9.61 |
1st UP Forecast | 7.86 |
1st DOWN Forecast | 2.88 |
2nd DOWN Forecast | 1.13 |
3rd DOWN Forecast | -0.61 |
4th DOWN Forecast | -3.44 |
AKYA Weekly Forecast
4th UP Forecast | 10.77 |
3rd UP Forecast | 9.04 |
2nd UP Forecast | 7.97 |
1st UP Forecast | 6.90 |
1st DOWN Forecast | 3.84 |
2nd DOWN Forecast | 2.77 |
3rd DOWN Forecast | 1.70 |
4th DOWN Forecast | -0.03 |
AKYA Forecast2024
4th UP Forecast | 29.05 |
3rd UP Forecast | 21.46 |
2nd UP Forecast | 16.76 |
1st UP Forecast | 12.07 |
1st DOWN Forecast | -1.33 |
2nd DOWN Forecast | -6.02 |
3rd DOWN Forecast | -10.72 |
4th DOWN Forecast | -18.31 |
Akoya Biosciences Inc ( NASDAQ USA Symbol : AKYA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AKYA Other Details
Segment | EQ | |
Market Capital | 483432096.00 | |
Sector | Healthcare | |
Industry | Medical Instruments & Supplies | |
Offical website | > echo $website ; ?> |
AKYA Address
AKYA Latest News
AKYA Business Profile
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. It provides two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational, and clinical research. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts. Address: 100 Campus Drive, Marlborough, MA, United States, 01752
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service